January 2010 PMID 25961975

The influence of low dose finasteride, a type II 5α-reductase inhibitor, on circulating neuroactive steroids.

Michaela Dušková, Martin Hill, Luboslav Stárka

Download social card

Mentions

Peak: 2 in Jul 2023

across 2 sources since Jun 2021

Extended reach

47,165

potential audience

Total likes

1,093

Video views

46,718

Mentions per month

Jun 2021 – Jul 2023

Where it's discussed

X / Twitter3 posts
YouTube2 videos

AI synopsis

What people are saying

The discussions reflect a cautious curiosity, with posts like '@Grimhood @ResilientDad you seen this guy? Interested in your thoughts' showing interest, while comments about older studies and misinformation hint at underlying skepticism. The tone varies from inquisitive to critical, demonstrating an awareness of the topic's complexity but limited deep engagement or broad impact.

AgreementNeither agree nor disagree

The discussions show mixed opinions, with at least one post questioning the validity of the research based on previous studies, indicating neither full agreement nor disagreement.

InterestModerate interest

There is a basic level of curiosity, especially from users who ask for opinions and refer to existing studies, but overall engagement remains moderate.

EngagementModerate engagement

Participants demonstrate some engagement by referencing the research and mentioning its implications, but don't dive deeply into scientific analysis.

ImpactNeutral impact

The posts suggest the publication prompts some thought about medical implications, but overall influence on opinion or practice appears limited at this stage.

Abstract in brief

Finasteride is a 5-reductase inhibitor used to treat benign prostatic hyperplasia and androgenetic alopecia with minimal side effects, but some cases report depression.
The study investigated how low-dose finasteride (1mg/day) affects neuroactive steroid levels in men with early androgenetic alopecia over four months.
Results showed a decrease in neuroactive steroids involved in brain function, suggesting that reduced levels of these steroids may contribute to the risk of depression associated with finasteride treatment.

Read the full abstract

All mentions

Understanding Post-Finasteride Syndrome with Dr. Peter Attia

Dr. Attia and Dr. Khera discuss the controversial Post-Finasteride Syndrome (PFS). This video explores the implications of finasteride use, addressing related conditions and controversies surrounding its effects on…

Haircafe · Jul 7, 2023 31,131 views

Finasteride and Alzheimer's Disease Risk Analysis

This video explores whether finasteride influences the development of Alzheimer's disease by examining neurosteroids like allopregnanolone, which impacts mood and stress responses, and their potential therapeutic…

Haircafe · Nov 26, 2022 15,587 views

Sir Danthel

@sirdanthel · X

@Grimhood @ResilientDad you seen this guy? Interested in your thoughts… https://t.co/WYTnbF9MVl

Jul 12, 2023 · 2 likes · 210 followers View post →

PfSpain

@pfspain1 · X

Mar 19, 2023 · 1 like · 63 followers View post →

Documents Delivered, LLC

@DocsDel · X

The influence of low dose finasteride, a type II 5α-reductase inhibitor, on circulating neuroactive steroids https://t.co/QemVl4actI

Jun 22, 2021 · 175 followers View post →